The Long and Short

Brown & Brown: a value play among insurance brokers

| May 3, 2024

This document is intended for institutional investors and is not subject to all of the independence and disclosure standards applicable to debt research reports prepared for retail investors. This material does not constitute research.

Brown & Brown (BRO: Baa3/BBB-) trades at the widest spreads in the insurance broker peer group. Their notes offer compelling value relative to larger peers such as Willis Towers Watson and Arthur J Gallagher well as industry leaders Aon and Marsh & McLennan. Beyond the individual credit, insurance brokers should benefit this year from rising commercial P&C rates, strong organic growth industrywide and improving margins. Investors can increase their position in the sector by adding exposure to Brown & Brown, which trades at a discount not just to the immediate peer group but to the broader insurance segment of the investment grade index.

Exhibit 1. Brown & Brown compared to the IG insurance broker peers

Source: Santander US Capital Markets LLC, Bloomberg/TRACE G-spread indications

With the debt of insurance brokers still trading close to the levels of property and casualty (P&C) and life insurance underwriters, the relative stability of the brokers looks like better relative value. Insurance brokerage credits offer stability relative to traditional property and casualty names, as ongoing underwriting risk and rate volatility impact the broader industry. Traditional P&C insurance underwriters struggled throughout 2022 and early 2023 amidst high levels of global catastrophe costs. Those market conditions helped create significant upward pricing pressure in the second half of 2023 that carried over into the current year, which should continue to benefit the profitability of the global insurance brokers. Furthermore, ongoing rate volatility creates investment portfolio risk that is much more present among insurance underwriters and has a more limited impact on the brokerage group. BRO offers good risk compensation relative to the rest of the peer group, with the widest trading bonds in the intermediate part of the credit curve.

BRO is the smallest of the investment grade insurance brokers with annual revenue of about $3.5 billion to $4.5 billion, which is roughly half that of the next largest competitors AJG and WTW. The company continues to expand through a combination of strategic bolt-on acquisitions and impressive organic revenue growth. Revenue has more than doubled since 2015. BRO is highly focused on the domestic market with over 90% of revenue generated but continues to target acquisitions to help expand its footprint outside of the US. In their recently released first quarter earnings, the company reported organic revenue growth of 8.6%, with total revenue growth of 12.7% when calculating additions through M&A.

BRO is notable among its peer group for boasting some of the highest profit margins in the industry. The EBITDA margin for fiscal 2023 was roughly 36%, which also carried over at that level in the first quarter of 2024. That compares with significantly lower profitability from most of the peer group for 2023: WTW (23.7%), AJG (28.5%), MMC (29.6%), with the exception of AON (36.3%).

BRO maintains a manageable liquidity profile with nearly $600 million in cash on the balance sheet, plus an additional $600 million available on the company’s undrawn credit facility. There’s a $500 million public debt maturity due in October of this year, which probably makes them a candidate to issue debt in the intermediate term. BRO’s last trip to the public debt market was in 2022 when it issued 10-year and 30-year debt. The company has no other public debt maturities until 2029 but has private loan maturities staggered over the next four years.

Given its growth aspirations, BRO had been running with slightly higher leverage than its industry peers at about 3.0x as of year-end 2023. However, the company is expected to bring leverage down to the 2.0-2.5x range in the near-term, which is highly appropriate for maintenance of investment grade ratings and closely in-line with the rest of the peer group. Most of the IG insurance brokers had been running in the 2.0-2.5x as of year-end 2023, with the exception of AJG which is also right around 3.0x in-line with BRO.

Dan Bruzzo, CFA
dan.bruzzo@santander.us
1 (646) 776-7749

This material is intended only for institutional investors and does not carry all of the independence and disclosure standards of retail debt research reports. In the preparation of this material, the author may have consulted or otherwise discussed the matters referenced herein with one or more of SCM’s trading desks, any of which may have accumulated or otherwise taken a position, long or short, in any of the financial instruments discussed in or related to this material. Further, SCM may act as a market maker or principal dealer and may have proprietary interests that differ or conflict with the recipient hereof, in connection with any financial instrument discussed in or related to this material.

This message, including any attachments or links contained herein, is subject to important disclaimers, conditions, and disclosures regarding Electronic Communications, which you can find at https://portfolio-strategy.apsec.com/sancap-disclaimers-and-disclosures.

Important Disclaimers

Copyright © 2024 Santander US Capital Markets LLC and its affiliates (“SCM”). All rights reserved. SCM is a member of FINRA and SIPC. This material is intended for limited distribution to institutions only and is not publicly available. Any unauthorized use or disclosure is prohibited.

In making this material available, SCM (i) is not providing any advice to the recipient, including, without limitation, any advice as to investment, legal, accounting, tax and financial matters, (ii) is not acting as an advisor or fiduciary in respect of the recipient, (iii) is not making any predictions or projections and (iv) intends that any recipient to which SCM has provided this material is an “institutional investor” (as defined under applicable law and regulation, including FINRA Rule 4512 and that this material will not be disseminated, in whole or part, to any third party by the recipient.

The author of this material is an economist, desk strategist or trader. In the preparation of this material, the author may have consulted or otherwise discussed the matters referenced herein with one or more of SCM’s trading desks, any of which may have accumulated or otherwise taken a position, long or short, in any of the financial instruments discussed in or related to this material. Further, SCM or any of its affiliates may act as a market maker or principal dealer and may have proprietary interests that differ or conflict with the recipient hereof, in connection with any financial instrument discussed in or related to this material.

This material (i) has been prepared for information purposes only and does not constitute a solicitation or an offer to buy or sell any securities, related investments or other financial instruments, (ii) is neither research, a “research report” as commonly understood under the securities laws and regulations promulgated thereunder nor the product of a research department, (iii) or parts thereof may have been obtained from various sources, the reliability of which has not been verified and cannot be guaranteed by SCM, (iv) should not be reproduced or disclosed to any other person, without SCM’s prior consent and (v) is not intended for distribution in any jurisdiction in which its distribution would be prohibited.

In connection with this material, SCM (i) makes no representation or warranties as to the appropriateness or reliance for use in any transaction or as to the permissibility or legality of any financial instrument in any jurisdiction, (ii) believes the information in this material to be reliable, has not independently verified such information and makes no representation, express or implied, with regard to the accuracy or completeness of such information, (iii) accepts no responsibility or liability as to any reliance placed, or investment decision made, on the basis of such information by the recipient and (iv) does not undertake, and disclaims any duty to undertake, to update or to revise the information contained in this material.

Unless otherwise stated, the views, opinions, forecasts, valuations, or estimates contained in this material are those solely of the author, as of the date of publication of this material, and are subject to change without notice. The recipient of this material should make an independent evaluation of this information and make such other investigations as the recipient considers necessary (including obtaining independent financial advice), before transacting in any financial market or instrument discussed in or related to this material.

The Library

Search Articles